Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07270380 · ClinicalTrials.gov registry record · NA
Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.
A NA study, sponsored by Biocomposites.
- Recruiting
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT07270380 is a NA study that is actively recruiting participants, run by Biocomposites. The registered enrollment target is 139 participants.
The verdict
NCT07270380, a NA study, is actively recruiting participants, sponsored by Biocomposites.
- RECRUITING
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.
Interventions
- DEVICE genex with gentamicin (genex G)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07270380
The ClinicalTrials.gov registry entry for NCT07270380 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biocomposites, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which genex with gentamicin (genex G) is the first listed.
NCT07270380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07270380 about?
NCT07270380 is a clinical study titled "Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.". The purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.
What is the current status of trial NCT07270380?
This trial is currently recruiting. It is a NA study. The enrollment target is 139 participants. The study started on 2026-06. Estimated completion is 2028-10.
What interventions are being tested in trial NCT07270380?
The interventions under investigation include: genex with gentamicin (genex G) (DEVICE).
Who is sponsoring clinical trial NCT07270380?
This trial is sponsored by Biocomposites, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.